Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-18-019811
Filing Date
2018-03-23
Accepted
2018-03-23 13:30:52
Documents
5
Effectiveness Date
2018-03-23

Document Format Files

Seq Description Document Type Size
1 DEFA14A a18-3261_3defa14a.htm DEFA14A 34891
2 GRAPHIC g32613bci001.gif GRAPHIC 62727
3 GRAPHIC g32613bci002.gif GRAPHIC 83919
4 GRAPHIC g32613bci003.gif GRAPHIC 24346
5 GRAPHIC g32613bci004.gif GRAPHIC 3940
  Complete submission text file 0001104659-18-019811.txt   277426
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

EIN.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35024 | Film No.: 18709528
SIC: 2833 Medicinal Chemicals & Botanical Products